Study Of Safety, Tolerability And Pharmacokinetics Of Subcutaneous Doses Of TA-46
Clinical trial NCT04410809 · COMPLETED
Trial details
- NCT number
- NCT04410809
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-19
- Primary completion
- 2019-11-27
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.